Your Shopping Cart Is Empty
| Report Code: A01716 | Nov 2020 | Pages: 205 | ||
| Tables: 61 | Charts: 75 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Ophthalmic Devices Market
Request Now !The global ophthalmic devices market size was valued at $53,428.8 million in 2019, and is projected to reach $66,719.3 million by 2027, registering a CAGR of 4.2% from 2020 to 2027.
The emergence of the novel coronavirus SARS-CoV-2, and the resulting disease COVID-19, has created a major international public health challenge. As the government has imposed lockdown, the ophthalmology diagnostics clinics are closed and the surgeries are postponed which is expected to limit the growth of the market.
Ophthalmology is a branch of medical science that deals with the structure, function, and various eye diseases. Ophthalmic devices are medical equipment designed for diagnosis, surgery, and vision correction. These devices gain increased importance and adoption due to high prevalence of various ophthalmic diseases such as glaucoma, cataract, and other vision-related issues.
Increase in prevalence of ophthalmic diseases such as cataract and glaucoma is a key factor that significantly drives the growth of the global ophthalmic devices market. In addition, surge in penetration of digital devices, including laptops, smartphones, and computers, e-readers; rapid technological advancements such as introduction of intraocular lenses (IOLs); and increase in focus on customer training and education among eye care professionals regarding eye diseases and associated complications notably contribute toward the growth of the global market. Furthermore, increase in R&D activities for novel devices development related to vision error and rise in awareness related to devices used in the field of ophthalmology are expected to propel the market growth. However, low awareness about eye-related diseases and dearth of skilled professionals are expected to hamper the growth of the market. On the contrary, the emerging countries such as China and India possess high growth potential, owing to the improving healthcare infrastructure in these countries.
The emergence of the novel coronavirus SARS-CoV-2 has created a major international public health challenge. This has impacted all sectors, disrupting the supply chain and creating a shortage of supplies. As the government has imposed lockdown, ophthalmology surgeries have been postponed. This is attributed to the fact that ophthalmologists are at high risk, considering the proximity to patients when diagnosing patients. Furthermore, the government has imposed guidelines for practice such as the use of teleophthalmology services for patients who require urgent follow-up.
Depending on product function, the report segments the global ophthalmic devices market into ophthalmic surgical devices, diagnostic devices, and vision care devices. The ophthalmic surgical devices segment is further categorized into refractive error surgical devices, glaucoma surgical devices, cataract surgical devices, and vitreoretinal surgical devices. The cataract surgery devices segment garnered the largest share in ophthalmic surgical devices market in 2019, owing to increase in prevalence of cataract each year, which resulted in increase in number of surgeries.
The global ophthalmic diagnostic devices segment is subdivided into refractors, corneal topography systems, retinal ultrasound systems, fundus camera, ophthalmoscopes, optical coherence tomography systems, perimeters, slit lamps, and tonometer. The optical coherence tomography systems (OCT) dominates the market in 2019, and is expected to continue the trend during the forecast period. This is attributed to extensive use of optical coherence tomography systems in drug discovery and their technological benefits such as ability to visualize in-depth structures of the eye, surface tissue, and vascular systems.
The vision care devices segment is bifurcated into contact lenses and spectacle lenses. The contact lenses segment is estimated to grow at the highest CAGR of 3.9% from 2020 to 2027. This is attributed to increase in preference for contact lenses over prescription eyeglasses, due to changes in lifestyle and increase in demand for innovative lenses.
Region wise, the ophthalmic devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The North America ophthalmic devices market accounted for the largest share in 2019; however, Asia-Pacific is anticipated to register the highest CAGR of 4.6% throughout the forecast period. According to the Center for Diseases Control and Prevention, diabetic retinopathy is expected to account for major cause of blindness in the U.S. From 2010 to 2050, the number of Americans with diabetic retinopathy is expected to nearly double from 7.7 million to 14.6 million. Glaucoma further contributes toward the loss of vision and blindness.
Asia-Pacific is projected to witness significant growth during the forecast period, due to increase in the incidence of ophthalmic diseases such as cataract, glaucoma, age-related macular degeneration (AMD), and refractive errors. Moreover, rise in geriatric population and increase in inclination toward surgical procedures for treatment contribute toward the ophthalmic devices market growth. Furthermore, large number of patients operated with glaucoma and cataract in the Asian countries provide major opportunity for manufacturers, which they can capitalize on to increase their ophthalmic devices market share
Ophthalmology devices market is highly competitive in nature, as major players are focusing on development and launch of innovative products to strengthen their foothold in the competitive market. The key players operating in the global ophthalmic devices market include Novartis AG, Carl Zeiss Meditec AG, Essilor International S.A., HAAG-Streit Holding AG, HOYA Corporation, Johnson & Johnson, Nidek Co., Ltd., Topcon Corporation, Valeant Pharmaceuticals International, Inc., and Ziemer Ophthalmic Systems AG. The other players in the industry are Sonomed Escalon, Hoya Group, Gulden Ophthalmics, FCI Ophthalmics, Glaukos Corporation, and STAAR Surgical.
These market players are adopting strategies such as mergers & acquisitions, product launch, and geographical expansions to attain maximum share of the industry and to strengthen their product portfolio. Furthermore, key players in the market are increasing their R&D investments to attain competitive advantage.
Key Benefits For Stakeholders
Key Market Segments
By Product Function
By Region
List of key players profiled in the report
Ophthalmic Devices Market Report Highlights
| Aspects | Details |
|---|---|
| By PRODUCT FUNCTION |
|
| By Region |
|
| Key Market Players | ESSILOR INTERNATIONAL S.A., JOHNSON & JOHNSON, .HOYA CORPORATION, TOPCON CORPORATION, .HAAG-STREIT HOLDING AG, NIDEK CO., LTD., BAUSCH HEALTH COMPANIES INC., ZIEMER OPHTHALMIC SYSTEMS AG, NOVARTIS AG (ALCON-A DIVISION OF NOVARTIS), CARL ZEISS MEDITEC AG |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.1.1.Key benefits for stakeholders
1.1.2.Key market segments
1.2.Research methodology
1.2.1.Secondary research
1.2.2.Primary research
1.2.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top winning strategies
3.2.2.Top player positioning, 2019
3.2.3.Key forces shaping the global ophthalmic devices market
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Rise in prevalence of eye-related diseases worldwide
3.3.1.2.Rapid technological advancements in ophthalmic
3.3.1.3.Increase in focus on customer training and education along with awareness
3.3.1.4.High adoption of digital devices worldwide
3.3.2.Restraints
3.3.2.1.Low awareness about eye-related diseases
3.3.2.2.Dearth of skilled professionals
3.3.3.Opportunities
3.3.3.1.Potential growth opportunities in emerging nations for ophthalmic devices manufacturers
3.4.Government regulations
3.4.1.FDA
3.4.2.CE Mark
3.4.3.Pharmaceuticals and Medical Devices Agency and Ministry of Health, Labor, and Welfare (MHLW)
3.5.Impact of COVID-19 on ophthalmic devices market
CHAPTER 4:OPTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION
4.1.Overview
4.1.1.Market size and forecast, by region
4.2.Surgical devices
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Refractive error surgical devices
4.2.3.1.Market size and forecast
4.2.3.2.Market size and forecast, by type
4.2.3.3.Excimers and femtosecond lasers
4.2.3.4.Market size and forecast
4.2.3.5.Microkeratomes
4.2.3.6.Market size and forecast
4.2.4.Glaucoma surgical devices
4.2.4.1.Market size and forecast
4.2.4.2.Market size and forecast, by type
4.2.4.3.Implants and stents
4.2.4.4.Market size and forecast
4.2.4.5.Glaucoma drainage devices
4.2.4.6.Market size and forecast
4.2.4.7.Glaucoma laser devices
4.2.4.8.Market size and forecast
4.2.5.Cataract surgical devices
4.2.5.1.Market size and forecast
4.2.5.2.Market size and forecast, by type
4.2.5.3.Intraocular lenses
4.2.5.4.Market size and forecast
4.2.5.5.Viscoelastic
4.2.5.6.Market size and forecast
4.2.5.7.Phacoemulsification systems
4.2.5.8.Market size and forecast
4.2.6.Vitreoretinal surgical devices
4.2.6.1.Market size and forecast
4.2.6.2.Market size and forecast, by type
4.2.6.3.Vitrectomy machines and vitrectomy packs
4.2.6.4.Market size and forecast
4.2.6.5.Photocoagulation lasers
4.2.6.6.Market size and forecast
4.2.6.7.Illumination devices
4.2.6.8.Market size and forecast
4.3.Diagnostic devices
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Refractors
4.3.3.1.Market size and forecast
4.3.4.Corneal topography systems
4.3.4.1.Market size and forecast
4.3.5.Retinal ultrasound systems
4.3.5.1.Market size and forecast
4.3.6.Fundus camera
4.3.6.1.Market size and forecast
4.3.7.Ophthalmoscopes
4.3.7.1.Market size and forecast
4.3.8.Optical coherence tomography systems
4.3.8.1.Market size and forecast
4.3.9.Perimeters
4.3.9.1.Market size and forecast
4.3.10.Slit lamps
4.3.10.1.Market size and forecast
4.3.11.Tonometer
4.3.11.1.Market size and forecast
4.4.Vision care devices
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Contact lenses
4.4.3.1.Market size and forecast
4.4.4.Spectacle lenses
4.4.4.1.Market size and forecast
CHAPTER 5:OPHTHALMIC DEVICES MARKET, BY REGION
5.1.Overview
5.1.1.Market size and forecast
5.2.North America
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by product function
5.2.3.Market size and forecast, by region
5.2.4.U.S.
5.2.4.1.Market size and forecast, by product function
5.2.5.Canada
5.2.5.1.Market size and forecast, by product function
5.2.6.Mexico
5.2.6.1.Market size and forecast, by product function
5.3.Europe
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by product function
5.3.3.Market size and forecast, by region
5.3.4.Germany
5.3.4.1.Market size and forecast, by product function
5.3.5.France
5.3.5.1.Market size and forecast, by product function
5.3.6.UK
5.3.6.1.Market size and forecast, by product function
5.3.7.Italy
5.3.7.1.Market size and forecast, by product function
5.3.8.Spain
5.3.8.1.Market size and forecast, by product function
5.3.9.Rest of the Europe
5.3.9.1.Market size and forecast, by product function
5.4.Asia-Pacific
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by product function
5.4.3.Market size and forecast, by region
5.4.4.Japan
5.4.4.1.Market size and forecast, by product function
5.4.5.China
5.4.5.1.Market size and forecast, by product function
5.4.6.Australia market size and forecast
5.4.6.1.Market size and forecast, by product function
5.4.7.India
5.4.7.1.Market size and forecast, by product function
5.4.8.Rest of Asia-Pacific
5.4.8.1.Market size and forecast, by product function
5.5.LAMEA
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by product function
5.5.3.Market size and forecast, by region
5.5.4.Brazil
5.5.4.1.Market size and forecast, by product function
5.5.5.Saudi Arabia market size and forecast
5.5.5.1.Market size and forecast, by product function
5.5.6.South Africa
5.5.6.1.Market size and forecast, by product function
5.5.7.Rest of LAMEA
5.5.7.1.Market size and forecast, by product function
CHAPTER 6:COMPANY PROFILES
6.1.CARL ZEISS MEDITEC AG
6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance
6.2.ESSILOR INTERNATIONAL S.A.
6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
6.2.5.Business performance
6.2.6.Key strategic moves and developments
6.3.HAAG-STREIT HOLDING AG
6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.4.HOYA CORPORATION
6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Business performance
6.4.5.Key strategic moves and developments
6.5.JOHNSON & JOHNSON
6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments
6.5.4.Product portfolio
6.5.5.Business performance
6.5.6.Key strategic moves and developments
6.6.NIDEK CO., LTD.
6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Key strategic moves & developments
6.7.NOVARTIS AG (ALCON-A DIVISION OF NOVARTIS)
6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Operating business segments
6.7.4.Product portfolio
6.7.5.Business performance
6.8.TOPCON CORPORATION
6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Operating business segments
6.8.4.Product portfolio
6.8.5.Business performance
6.9.BAUSCH HEALTH COMPANIES INC.
6.9.1.Company overview
6.9.2.Company snapshot
6.9.3.Operating business segments
6.9.4.Product portfolio
6.9.5.Business performance
6.10.ZIEMER OPHTHALMIC SYSTEMS AG
6.10.1.Company overview
6.10.2.Company snapshot
6.10.3.Product portfolio
6.11.List of mergers and acquisitions (M&A) activities
LIST OF TABLES
TABLE 01.GLOBAL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 02.GLOBAL OPHTHALMIC SURGICAL DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 03.GLOBAL REFRACTIVE ERROR SURGERY DEVICES MARKET, BY TYPE 2019-2027
TABLE 04.GLOBAL GLAUCOMA SURGICAL DEVICES MARKET, BY TYPE 2019-2027
TABLE 05.GLOBAL CATARACT SURGERY DEVICES MARKET, BY TYPE 2019-2027
TABLE 06.GLOBAL VITREORETINAL EYE SURGERY MARKET, BY TYPE 2019-2027
TABLE 07.OPHTHALMIC DIAGNOSTIC DEVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 08.OPHTHALMIC VISION CARE DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 09.OPHTHALMIC DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 10.NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 11.NORTH AMERICA OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 12.U.S. OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 13.CANADA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 14.MEXICO OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 15.EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 16.EUROPE OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 17.GERMANY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 18.FRANCE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 19.UK OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 20.ITALY OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 21.SPAIN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 22.REST OF EUROPE OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 23.ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 24.ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 25.JAPAN OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 26.CHINA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 27.AUSTRALIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 28.INDIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 29.REST OF ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 30.LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 31.LAMEA OPHTHALMIC DEVICES MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 32.BRAZIL OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 33.SAUDI ARABIA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 34.SOUTH AFRICA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 35.REST OF LAMEA OPHTHALMIC DEVICES MARKET, BY PRODUCT FUNCTION, 2019–2027 ($MILLION)
TABLE 36.CARL ZEISS: COMPANY SNAPSHOT
TABLE 37.CARL ZEISS: OPERATING SEGMENTS
TABLE 38.CARL ZEISS: PRODUCT PORTFOLIO
TABLE 39.ESSILOR: COMPANY SNAPSHOT
TABLE 40.ESSILOR: OPERATING SEGMENTS
TABLE 41.ESSILOR: PRODUCT PORTFOLIO
TABLE 42.HAAG-STREIT: COMPANY SNAPSHOT
TABLE 43.HAAG-STREIT: OPERATING SEGMENTS
TABLE 44.HOYA: COMPANY SNAPSHOT
TABLE 45.HOYA: OPERATING SEGMENTS
TABLE 46.J&J: COMPANY SNAPSHOT
TABLE 47.J&J: OPERATING SEGMENTS
TABLE 48.J&J: PRODUCT PORTFOLIO
TABLE 49.NIDEK: COMPANY SNAPSHOT
TABLE 50.NIDEK: OPERATING SEGMENTS
TABLE 51.NOVARTIS: COMPANY SNAPSHOT
TABLE 52.NOVARTIS: OPERATING SEGMENTS
TABLE 53.NOVARTIS: PRODUCT PORTFOLIO
TABLE 54.TOPCON: COMPANY SNAPSHOT
TABLE 55.TOPCON: OPERATING SEGMENTS
TABLE 56.TOPCON: PRODUCT PORTFOLIO
TABLE 57.BAUSCH HEALTH COMPANIES: COMPANY SNAPSHOT
TABLE 58.BAUSCH HEALTH COMPANIES : OPERATING SEGMENTS
TABLE 59.BAUSCH HEALTH COMPANIES: PRODUCT PORTFOLIO
TABLE 60.ZEIMER: COMPANY SNAPSHOT
TABLE 61.ZIEMER: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL OPHTHALMIC DEVICES MARKET SEGMENTATION
FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2016–2020
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016–2020 (%)
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2016–2020
FIGURE 05.TOP PLAYER POSITIONING, 2019
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTION
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE COMPETITVE RIVARLY
FIGURE 11.MARKET DYNAMICS FOR OPHTHALMIC DEVICES MARKET
FIGURE 12.GLOBAL REFRACTIVE ERROR SURGERY DEVICES MARKET, 2019-2027
FIGURE 13.GLOBAL EXCIMERS AND FEMTOSECOND LASERS MARKET, 2019-2027 ($MILLION)
FIGURE 14.GLOBAL MICROKERATOMES MARKET, 2019-2027 ($MILLION)
FIGURE 15.GLOBAL GLAUCOMA SURGICAL DEVICES MARKET, 2019-2027
FIGURE 16.GLOBAL IMPLANTS & STENTS MARKET, 2019-2027 ($MILLION)
FIGURE 17.GLOBAL GLAUCOMA DRAINAGE DEVICES MARKET, 2019-2027 ($MILLION)
FIGURE 18.GLOBAL GLAUCOMA LASER DEVICES MARKET, 2019-2027 ($MILLION)
FIGURE 19.GLOBAL CATARACT SURGERY DEVICES MARKET, 2019-2027
FIGURE 20.GLOBAL INTRAOCULAR LENSES MARKET, BY TYPE 2019-2027
FIGURE 21.GLOBAL VISCOELASTICS MARKET, BY TYPE 2019-2027
FIGURE 22.GLOBAL PHACOEMULSIFICATION MARKET, BY TYPE 2019-2027
FIGURE 23.GLOBAL VITREORETINAL EYE SURGERY DEVICES MARKET, 2019-2027
FIGURE 24.GLOBAL VITRECTOMY MACHINES AND VITRECTOMY PACKS MARKET, BY TYPE 2019-2027
FIGURE 25.GLOBAL PHOTOCOAGULATION MARKET, 2019-2027
FIGURE 26.GLOBAL ILLUMINATIN DEVICES MARKET, 2019-2027
FIGURE 27.GLOBAL REFRACTORS MARKET, 2019–2027 ($MILLION)
FIGURE 28.GLOBAL CORNEAL TOPOGRAPHY SYSTEMS MARKET, 2019–2027 ($MILLION)
FIGURE 29.GLOBAL RETINAL ULTRASOUND SYSTEMS MARKET, 2019–2027 ($MILLION)
FIGURE 30.GLOBAL FUNDUS CAMERA MARKET, 2019–2027 ($MILLION)
FIGURE 31.GLOBAL OPHTHALMOSCOPES MARKET, 2019–2027 ($MILLION)
FIGURE 32.GLOBAL OPTICAL COHERANCE TOMPGRAPHY SYSTEMS MARKET, 2019–2027 ($MILLION)
FIGURE 33.GLOBAL PERIMETERS MARKET, 2019–2027 ($MILLION)
FIGURE 34.GLOBAL SLIT LAMPS MARKET, 2019–2027 ($MILLION)
FIGURE 35.GLOBAL TONOMETERS MARKET, 2019–2027 ($MILLION)
FIGURE 36.GLOBAL CONTACT LENSES MARKET, 2019–2027 ($MILLION)
FIGURE 37.GLOBAL SPECTACLE LENSES MARKET, 2019–2027 ($MILLION)
FIGURE 38.U.S. OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 39.CANADA OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 40.MEXICO OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 41.GERMANY OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 42.FRANCE OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 43.UK OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 44.ITALY OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 45.SPAIN OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 46.REST OF THE EUROPE OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 47.JAPAN OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 48.CHINA OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 49.AUSTRALIA OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 50.INDIA OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 51.REST OF ASIA-PACIFIC OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 52.BRAZIL OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 53.SAUDI ARABIA OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 54.SOUTH AFRICA OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 55.REST OF LAMEA OPHTHALMIC DEVICES MARKET, 2019–2027 ($MILLION)
FIGURE 56.CARL ZEISS: REVENUE, 2017-2019 ($MILLION)
FIGURE 57.CARL ZEISS: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 58.CARL ZEISS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 59.ESSILOR: REVENUE, 2017-2019 ($MILLION)
FIGURE 60.ESSILOR: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 61.HOYA: REVENUE, 2017-2019 ($MILLION)
FIGURE 62.HOYA: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 63.HOYA: REVENUE SAHRE FOR LIFE CARE SEGMENT, 2019 (%)
FIGURE 64.HOYA: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 65.J&J: REVENUE, 2017-2019 ($MILLION)
FIGURE 66.J&J: REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 67.J&J: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 68.NOVARTIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 69.NOVARTIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 70.NOVARTIS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 71.TOPCON: REVENUE, 2016-2018 ($MILLION)
FIGURE 72.TOPCON: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 73.BAUSCH HEALTH COMPANIES : REVENUE, 2017-2019 ($MILLION)
FIGURE 74.BAUSCH HEALTH COMPANIES : REVENUE SHARE BY SEGMENT, 2019 (%)
FIGURE 75.BAUSCH HEALTH COMPANIES: REVENUE SHARE BY REGION, 2019 (%)
The ophthalmic devices market is expected to witness steady growth in the future. The market has drawn the interest of the healthcare industry, owing to increase in prevalence of eye-related diseases, globally.
The ophthalmic devices market is dominated by well-established players; hence, the market witnesses intense competition. The adoption of these devices has increased considerably, owing to increase in prevalence of eye-related diseases, which propels the market growth. In addition, increase in product launches is expected to contribute toward the growth market. As per the analysis in the report, the use of ophthalmic devices is highest in North America, owing to higher number of product approvals, followed by product launches.
A. Ophthalmology is a branch of medical science that deals with the structure, function, and various eye diseases
A. Ophthalmologic devices is a medical equipment designed for diagnosis, surgery, and vision correction
A. The base year calculated is 2019 in the report.
A. The total value of ophthalmic devices market was $53,428.8 million in 2019.
A. The forecast period in the report is from 2020-2027.
A. The market value of opthalmic devices market in 2027 was $66,719.3 million.
A. Rising prevalence of eye related diseases, technological advancements and increases awareness among people will drive the market according to the KOLs
A. The market has drawn the interest of the healthcare industry, owing to an increase in prevalence of eye-related diseases, globally.
A. Vision care segment holds the maximum market share.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as India with a CAGR of 4.6%. increase in the incidence of ophthalmic diseases such as cataract, glaucoma, AMD, and refractive errors. Moreover, a rise in geriatric population and increase in inclination toward surgical procedures for treatment contribute toward the market growth.
Start reading instantly.
This Report and over 67,543+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report